ClinicalTrials.Veeva

Menu

Trial Comparing Relapse Rates Between Standard Ureteroscopic Removal Of Ureteral Stone And Standard Removal With Additional Ureterorenic Clearing Of Non-Symptomatic Stones In The Kidney

I

Indiana Kidney Stone Institute

Status

Completed

Conditions

Ureteral Stones, Kidney Stones

Treatments

Procedure: Asymptomatic kidney stones and ureteral stone removed
Procedure: Symptomatic stone removal

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT02210650
P01 DK 043881 Project 3

Details and patient eligibility

About

Patients with a ureteral or kidney stone that causes symptoms, like pain, frequently have small kidney stones that don't cause symptoms. If these small kidney stones are determined to be asymptomatic (not causing any problems or pain), then most urologists will simply remove the symptomatic ureteral stone and leave the additional stones in the kidneys. However, symptomatic kidney stones started as small stones that didn't cause symptoms. This means that the small stones remaining in the patient's kidney may cause problems later. The purpose of our research is to test if removing small stones from the kidney prevents future stone episodes.

Enrollment

75 patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Scheduled to undergo surgery (URS or PCNL) for a primary stone.
  • Computed tomography (CT) exam within the 90-day pre-operative period
  • Small (≤ 6mm) asymptomatic stones in visible on KUB or CT (i.e., calcium stones) in the contralateral kidney for a primary renal stone or ipsilateral kidney for primary ureteral stone.
  • Recurrent (having had previous stones) or multiple (simultaneous bilateral stones) stones
  • Able to give informed consent
  • Age 21 years or older

Exclusion criteria

  • Inability to give informed consent
  • Age less than 21 years
  • Stones not visible on KUB or CT
  • Patients with systemic disease or renal anatomical disorders (RTA, primary hyperparathyroidism, sarcoidosis, enteric hyperoxaluria, medullary sponge kidney)
  • Any condition (eg, psychiatric illness) or situation that, in the investigator's opinion, could put the
  • subject at significant risk, confound the study results, or interfere significantly with the subject's
  • participation in the study.
  • Unwilling to participate.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

75 participants in 2 patient groups

Symptomatic stone removal
Other group
Description:
Group 1 will receive the standard treatment of having only the symptomatic stone removed
Treatment:
Procedure: Symptomatic stone removal
Asymptomatic kidney stones and symptomatic stone removed
Other group
Description:
Group 2 will include the step of having the asymptomatic kidney stones removed in addition to the symptomatic stone
Treatment:
Procedure: Asymptomatic kidney stones and ureteral stone removed

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems